
GSK vs QUCY
$GSK vs $QUCY head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
GSK vs QUCY: trend, levels and the market
One year to 2026-11-20, against the S&P 500 (+3.6%). Split-adjusted daily closes.
- ·Neither kept up with the market over the past year: GSK -12% and QUCY -32.5%, against the S&P 500 at +3.6%.
- ·QUCY has support 18.1% below at $0.43; GSK has no tested support within 35% under its price.
Support and resistance are daily prices the stock has turned at three or more times, within 35% of the price. The loading zone is the nearby price where the heaviest volume traded. These describe where a stock has been, not where it will go. Not investment advice.
GSK vs QUCY: the quick read
- ·GSK is the larger company by market cap ($95.73B vs $45M).
- ·GSK has been more active on our scanner (78 vs 19 alerts in 30 days).
- ·QUCY has the smaller float (86.5M vs 2.00B), which tends to mean sharper, more volatile moves.
- ·Both are pharmaceutical preparations names, so this is a like-for-like comparison and sector news tends to move them together.
- ·They trade in different worlds by share price: QUCY is a low-priced stock where a few cents is a real percentage move, while the other is priced for steadier increments.
- ·GSK draws far more of our scanner's attention, 78 unusual-volume alerts in 30 days against 19, so it is the more actively traded of the two by some distance.
- ·They are not really peers by size: GSK is more than 2143x the market cap of QUCY, so the same dollar of news moves QUCY far harder.
- ·Both sit in the bottom quarter of their 52-week range, so this is a comparison of two names well off their highs.
- ·GSK pays a dividend and QUCY does not, which usually means one is being held for income and the other for the move.
- ·They are pulling apart today: GSK is outperforming the other by roughly 5.9 percentage points on the session.
Objective differences only. Not investment advice.
Watching GSK or QUCY? Get each morning’s movers by email
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing GSK and QUCY on TheDesperateTrader.
- Is GSK or QUCY the better stock?
- "Better" depends on your goal, and these two are not alike. GSK is the larger company by market cap ($95.73B vs $45M). GSK has been more active on our scanner (78 vs 19 alerts in 30 days). QUCY has the smaller float (86.5M vs 2.00B), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between GSK and QUCY?
- The differences that matter: GSK is roughly 2143x the size of the other by market cap ($95.73B vs $45M); they trade at very different share prices ($47.96 vs $0.52); GSK sits at 14% of its 52-week range against 5% for QUCY; only GSK pays a dividend; our scanner flagged GSK 78 times in the last 30 days against 19 for QUCY. Everything above is measured from the latest completed session and SEC filings.
- Which of GSK and QUCY is more active right now?
- Right now GSK is at about 0.6x its normal volume and QUCY is at about 0.7x, so QUCY is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is GSK or QUCY in the stronger trend?
- GSK is below its 50-day average of $49.31 and below its 200-day average of $52.25; QUCY is below its 50-day average of $1.03. GSK leads 4 of the 5 measures on this page (1 year, vs S&P 500, 3 months, 1 month, trend). A trend is where a stock has been, not a forecast, and nothing here is investment advice.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading GSK or QUCY? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysExplore the market
Free, live market tools. No account required to look.